Journal
TRENDS IN GENETICS
Volume 35, Issue 10, Pages 754-767Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tig.2019.07.004
Keywords
-
Categories
Funding
- National Institutes of Health (NIH) [1R35GM131687, 1R01GM115710, 1R01GM122926]
- NIH [T32GM007223, F31AG058405, F31DE026946]
- Breast Cancer Alliance
Ask authors/readers for more resources
Ribosomopathies are a diverse subset of diseases caused by reduced expression of, or mutations in, factors necessary for making ribosomes, the protein translation machinery in the cell. Despite the ubiquitous need for ribosomes in all cell types, ribosomopathies manifest with tissue-specific defects and sometimes increased cancer susceptibility, but few treatments target the underlying cause. By highlighting new research in the field, we review current hypotheses for the basis of this tissue specificity. Based on new work, we broaden our understanding of the role of ribosome biogenesis in diverse tissue types throughout embryonic development. We also pose the question of whether previously described human conditions such as aging can be at least partially attributed to defects in making ribosomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available